Publications

Final HPC report on the outcome of the Mass General Brigham PIP.

In this annual report for 2024, the HPC presents new research to enhance the collective understanding of health care spending trends and cost drivers and evaluates progress in meeting the Commonwealth’s cost containment, care delivery, and payment system goals.

This issue of the HPC’s DataPoints series explores trends in GLP-1 prescriptions in Massachusetts through September 2023 and examines the use and spending impacts of these drugs in the Commonwealth.

This policy brief describes the business model of private equity, provides a literature review of private equity’s impact on health care, and presents a novel analysis of health care provider mergers and acquisitions in Massachusetts from 2013 to 2023. In addition, the brief summarizes potential policy approaches to enhance transparency and oversight to minimize the potential harms of private equity involvement in health care.

Presented at the 2024 AcademyHealth Annual Research Meeting

In this annual report for 2023, the HPC presents new research to enhance the collective understanding of health care spending trends and cost drivers and evaluates progress in meeting the Commonwealth’s cost containment, care delivery, and payment system goals.

Pursuant to Mass. general laws ch.111, § 25C(g) and (i) and the Department of Public Health’s (DPH) regulations at 105 CMR 100.405(D), the Health Policy Commission (HPC) submits the following comment regarding the above-referenced matters and the independent cost-analyses (ICAs) thereof for consideration by DPH and the applicant, Mass General Brigham (MGB).

This legislatively-mandated report analyzes the impact of COVID-19 on the health care delivery system in Massachusetts, including short-term and long-term implications.

This legislatively-mandated report examines the use and impact of prescription drug coupons in Massachusetts, focusing on coupons issued by pharmaceutical manufacturers that reduce a commercial patient’s cost-sharing.

In this issue of DataPoints, the HPC uses data from the MA-RPO program, a first-in-the-nation statutory reporting requirement designed to collect public, standardized information on the structures and relationships of large Massachusetts providers, to examine physician affiliations and changes in the physician market.